StockData
Biodesix Inc logo

Biodesix Inc (BDSX) stock

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.40−0.48 (-5.41%)

Close on Nov 18, 2026Market cap $88.63MP/E –Yield –

Biodesix shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Biodesix's shares outstanding was 10M at Jun 30, 2026. For fiscal 2025 it was 8M, up 16.7% from the year before. The highest annual figure on record is 82M in fiscal 2023.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20258M+16.7%
FY2024Dec 31, 20246M-92.1%
FY2023Dec 31, 202382M+95.0%
FY2022Dec 31, 202242M+53.9%
FY2021Dec 31, 202127M+465.6%
FY2020Dec 31, 20205M+1899.2%
FY2019Dec 31, 20190M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202610M+40.4%
Q1 FY2026Mar 31, 202610M+32.3%
Q4 FY2025Dec 31, 20258M+10.0%
Q3 FY2025Sep 30, 20258M+2.5%
Q2 FY2025Jun 30, 20257M-94.2%
Q1 FY2025Mar 31, 20257M-92.5%
Q4 FY2024Dec 31, 20247M-92.1%
Q3 FY2024Sep 30, 20247M-90.8%
Q2 FY2024Jun 30, 2024127M+62.0%
Q1 FY2024Mar 31, 202497M+24.9%
Q4 FY2023Dec 31, 202392M+60.6%
Q3 FY2023Sep 30, 202380M+97.1%
Q2 FY2023Jun 30, 202379M+100.1%
Q1 FY2023Mar 31, 202378M+150.3%
Q4 FY2022Dec 31, 202258M+112.7%
Q3 FY2022Sep 30, 202240M+44.2%
Q2 FY2022Jun 30, 202239M+1457.0%
Q1 FY2022Mar 31, 202231M+16.8%
Q4 FY2021Dec 31, 202127M+9668.6%
Q3 FY2021Sep 30, 202128M+10100.4%
Q2 FY2021Jun 30, 20213M+865.6%
Q1 FY2021Mar 31, 202127M+9790.0%
Q3 FY2020Sep 30, 20200M+13.5%
Q2 FY2020Jun 30, 20200M–
Q1 FY2020Mar 31, 20200M–
Q4 FY2019Dec 31, 20190M–
Q3 FY2019Sep 30, 20190M–

More Biodesix figures

See a number that looks wrong?